Service agreement
Ended Awarded
- Contract number
- 75N91021F00033
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,637
Award facts
- Contract value 100% obligated
- $15,637.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $15,637.48 firm fixed price service agreement to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on December 16, 2020, with an ultimate completion date of December 19, 2021. This contract was issued as a call under a Blanket Purchase Agreement (BPA) with no set-aside designation, indicating competitive procurement. The work is to be performed in Carlsbad, California. Life Technologies Corporation, a prominent manufacturer of scientific instruments, reagents, and consumables, supplies specialized biotechnology products and services to multiple federal agencies, including the National Institutes of Health, Department of Defense, and the Centers for Disease Control and Prevention.
As a parent contractor with Thermo Electron Corporation as its parent entity, Life Technologies maintains significant federal contract vehicles, including a $3.5 million multi-award BPA with the Federal Bureau of Investigation and a single-award contract with Veterans Integrated Service Network 16. The company's federal contract portfolio typically encompasses preventative maintenance services, equipment repairs, technical support, and supplies of advanced scientific instruments such as real-time PCR systems, flow cytometers, and genetic analyzers. This NCI service agreement aligns with the company's core offerings in supporting critical research missions across the federal government.
Quick answers
Who was awarded contract 75N91021F00033?
75N91021F00033 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on December 16, 2020.
How much is contract 75N91021F00033 worth?
The government has obligated $15,637 on 75N91021F00033.
Is contract 75N91021F00033 an order under another contract?
Yes. 75N91021F00033 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91021F00033 competed?
The extent of competition for 75N91021F00033 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award